Dendritic cells generated from induced pluripotent stem cells and by direct reprogramming of somatic cells
European Journal of Immunology, vol. 52, pp. 1880–1888
Abstract
Novel and exciting avenues allow generating dendritic cells (DC) by reprogramming of somatic cells. DC are obtained from induced pluripotent stem cells (iPS cells), referred to as ipDC, and by direct reprogramming of cells toward DC, referred to as induced DC (iDC). iPS cells represent pluripotent stem cells generated by reprogramming of somatic cells and can differentiate into all cell types of the body, including DC. This makes iPS cells and ipDC derived thereof useful for studying various DC subsets, acquiring high cell numbers for research and clinical use, or applying genome editing to generate DC with wanted properties. Thereby, ipDC overcome limitations in specific DC subsets, which are only found in low abundance in blood or lymphoid organs. iDC are generated by direct reprogramming of somatic cells with a specific set of transcription factors and offer an avenue to obtain DC without a pluripotent cell intermediate. ipDC and iDC retain patient and disease-specific mutations and this opens new perspectives for studying DC in disease. This review summarizes the current techniques used to generate ipDC and iDC, and the types and functionality of the DC generated.
Authors 2
-
RWTH Aachen University · Universitätsklinikum Aachen
Affiliation as printed
Department of Cell and Tumor Biology RWTH Aachen University Hospital Aachen Germany
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation RWTH Aachen University Medical Center Aachen Germany
Department of Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Center, Aachen, Germany
-
Martin Zenke corresponding Aachen Department of Cell Biology Institute of Biomedical Engineering Department of Hematology, Oncology
RWTH Aachen University · Universitätsklinikum Aachen
Affiliation as printed
Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) Aachen Germany
Department of Cell Biology, Institute of Biomedical Engineering RWTH Aachen University Medical School Aachen Germany
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation RWTH Aachen University Medical Center Aachen Germany
Helmholtz Institute for Biomedical Engineering RWTH Aachen University Aachen Germany
Department of Cell Biology, Institute of Biomedical Engineering RWTH Aachen University Medical School Aachen Germany
Department of Cell Biology, Institute of Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Center, Aachen, Germany
Cited by 4 stored of 4
4 results
No patents citing this paper on Lens.org (checked 2026-10-06).